human cancersIron chelatorscancer immunotherapy
…eveal that the LTO1/YAE1 complex is frequently overexpressed in human cancers, where it negatively regulates MHC-I. Moreover, low doses of ir…
11articles mentioning diseases
12disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: human cancers ×
human cancers
This disease is selected. Its supporting articles are shown below.
Articles mentioning human cancers
11 articles · page 1 of 1human cancersDKK1 peptide-HLA-A2 complex
…oclonal antibodies against DKK1 peptide-HLA-A2 complex to treat human cancers. J Immunother Cancer 2024;121:e008145. doi: 10.1136/jitc-2023–0…
81.6%
viral infectionsautoimmune disordershuman cancers
…otoxic activity (CD4+CTLs) have been reported in the context of viral infections, autoimmune disorders, and more recently in patients with vario…
COADUVMPAADSTADhuman cancersUCEC cancers
… vaccines based on shared mutated NeoAgs might be developed for COAD, STAD and UCEC cancers, with a global coverage, and for PAAD an…
solid tumorshuman cancersSTAR0602invikafusp alfaSTART-001
…specific antibody, as monotherapy in patients with antigen-rich solid tumors resistant to anti-PD(L)1: Journal for ImmunoTherapy of Cancer. …
solid tumorshuman cancersPC3 prostate cancerhuman prostate cancerDana-Farber Cancer InstituteBrigham and Women’s Hospital Crimson CoreCARM1
…dentify additional genetic regulators of CAR-T cell activity in solid tumors.Ethics Approval The animal work described in this abstract was …
solid malignancieshuman cancersCT26EMT6EntinostatSTAR0602mSTAR1302
…only underlie resistance to immune checkpoint blockade (ICB) in solid malignancies. Novel combination therapies may overcome these barriers, provi…
solid malignancieshuman cancersEMT6MC38EntinostatSTAR0602mSTAR1302
…AR0602 in combination with HDAC inhibitors for the treatment of solid malignancies including those resistant to current ICB therapies.…
solid tumorshuman cancersUniversity of PennsylvaniaIFNγ
…Background Macrophages pervade solid tumors where they predominantly contribute to tumor progression but al…
human cancersHMTEVVRHCH2-ScDb
…Background Mutant forms of p53 are present in most human cancers, but targeting these proteins remains a major challenge. The re…
human cancersimmunotherapyanticancer treatment
…s differences between human and rodent immunobiology. Moreover, human cancers progressively develop in nature over long periods, while precli…